Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved tags : For save search
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
Published: 2024-04-18 (Crawled : 23:00) - biospace.com/
TAK | News | $13.16 0.08% 0.0% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
entyvio fda disease active for therapy
Glacier Bancorp, Inc. Receives Regulatory Approval for Acquisition of Six Montana Branches From HTLF Bank
Published: 2024-04-18 (Crawled : 20:00) - globenewswire.com
GBCI | News | $35.1 0.8% 0.0% 830K
|
Finance
| Email alert
Add to watchlist
HTLF | News | $33.52 1.55% 1.52% 200K
|
Finance
| Email alert
Add to watchlist
FRBA | News | $12.14 0.66% 0.66% 51K
|
Finance
| Email alert
Add to watchlist
six approval acquisition for
Teva, Alvotech Secure FDA Approval for Stelara Biosimilar with Early 2025 Launch
Published: 2024-04-18 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
fda biosimilar approval for stelara
Terran Biosciences Granted US Patent for the World’s First New Forms of MDMA, Potentially Clearing the Path to a Future 505(b)(2) Approval
Published: 2024-04-17 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
| Email alert
Add to watchlist
first patent granted approval for
Foresight Granted Patent Approval in Japan for All-Weather and Lighting Conditions Vision System
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
FRSX | $1.04 -8.77% -9.62% 130K
|
Finance
|
| O: 0.0%
H: 1.74%
C: -0.87%
patent japan granted approval system vision for
Elys BMG Group Announces Approval for The Ugly Mug Sportsbook in Washington, DC.
Published: 2024-04-17 (Crawled : 13:00) - globenewswire.com
ELYS | $0.1351 14.4% 130K
|
Consumer Services
| Email alert
Add to watchlist
approval group for
Jaguar Health Licenses FDA-Approved Oral Mucositis Product for U.S. Market, Initiating Commercial Footprint in its Core Focus Area of Cancer Supportive Care
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
JAGX | $0.1772 7.46% 6.94% 68M
|
Health Technology
|
| O: 26.26%
H: 73.2%
C: 18.87%
health cancer care for commercial
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Published: 2024-04-15 (Crawled : 13:00) - biospace.com/
TARO | $42.19 -0.12% 0.0% 31K
|
Health Technology
|
| O: 0.19%
H: 0.28%
C: 0.0%
approval for meeting
Provident Financial Services, Inc. Receives Federal Reserve Board Approval for its Merger with Lakeland Bancorp, Inc.
Published: 2024-04-11 (Crawled : 23:00) - globenewswire.com
PFS | News | $13.75 0.95% 0.0% 710K
|
Finance
|
| O: 1.18%
H: 3.5%
C: 2.4%
LBAI | News | $11.38 1.07% 1.05% 290K
|
Finance
|
| O: 0.36%
H: 4.91%
C: 3.84%
reserve approval for financial
Kiora Pharmaceuticals Receives Grant from Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study
Published: 2024-04-11 (Crawled : 17:00) - biospace.com/
KPRX | $0.4913 -2.94% -3.03% 160K
|
Manufacturing
|
| O: 3.23%
H: 0.16%
C: -1.79%
granted approval pharmaceuticals research for grant trial foundation study
FASENRA approved for treatment of children aged 6 to 11 with severe asthma
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
AZNCF | $140.15 -4.19% 560
|
Health Technology
|
| O: 1.47%
H: 1.16%
C: -1.27%
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: 3.34%
H: 0.27%
C: -0.62%
children approved treatment for
Japanese Ministry of Agriculture Grants New Approval for Broccoli Solutions
Published: 2024-04-10 (Crawled : 17:00) - agrofresh.com
PSMMY | $31.63 -1.02% 18K
|
Construction
|
| O: -0.67%
H: 0.0%
C: -1.77%
approval solutions for agriculture grants
Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication
Published: 2024-04-10 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.315 -8.68% -9.51% 8M
|
Health Technology
|
| O: 2.92%
H: 3.41%
C: 2.27%
ocu400 approval positive for therapy
Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
VVOS | $2.66 -2.66% 63K
|
Health Technology
|
| O: -0.33%
H: 13.91%
C: -8.77%
approval care for medical
Gogo Secures FCC Regulatory Approval for Gogo Galileo Terminals
Published: 2024-04-09 (Crawled : 11:00) - prnewswire.com
GOGO | News | $8.385 1.76% 1.73% 580K
|
Communications
|
| O: 1.81%
H: 8.04%
C: 3.43%
approval for
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.91 0.58% 0.58% 1.1M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
ViiV Healthcare announces U.S. FDA approval of Dovato (dolutegravir/lamivudine) for adolescents living with HIV
Published: 2024-04-08 (Crawled : 13:30) - biospace.com/
PFE A | $25.39 -0.12% -0.12% 36M
|
Health Technology
|
| O: -0.39%
H: 0.0%
C: 0.0%
fda approval for hiv living
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
VERO | $0.7816 0.89% 0.88% 55K
|
Health Technology
|
| O: 1.51%
H: 0.0%
C: -9.59%
approval for max
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Published: 2024-04-08 (Crawled : 12:00) - globenewswire.com
CCCC | $6.91 0.58% 0.58% 1.1M
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 association approved cancer care research preclinical for meeting therapeutics
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.